SCHEMBL17994136

SCHEMBL17994136

C=CCn1c(I)nc2c(N3CCOCC3)nc(C=C)nc21

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 12/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 7/20 0.39
ALDH1A1 P00352 12/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 11/20 0.35
HPGD P15428 11/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 2/20 0.34
SLC29A1 Q99808 1/20 0.33
CASP1 P29466 1/20 0.32
MAPT P10636 1/20 0.31
PDE10A Q9Y233 2/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937775 0.85 HSD17B10 (0.41) HSD17B10POLBCYP3A4ALDH1A1SMN1; SMN2
SCHEMBL9937364 0.65 CYP3A4 (0.41) HSD17B10CYP3A4ALDH1A1SMN1; SMN2KDM4E
SCHEMBL25229551 0.64 CYP3A4 (0.45) HSD17B10POLBCYP3A4ALDH1A1SMN1; SMN2
SCHEMBL9936490 0.64 CYP3A4 (0.40) HSD17B10CYP3A4ALDH1A1SMN1; SMN2KDM4E
SCHEMBL9937539 0.63 CYP3A4 (0.41) HSD17B10CYP3A4ALDH1A1SMN1; SMN2KDM4E
SCHEMBL30076358 0.63 CYP3A4 (0.41) HSD17B10CYP3A4ALDH1A1SMN1; SMN2KDM4E
SCHEMBL23505746 0.62 HTT (0.49) HSD17B10POLBCYP3A4ALDH1A1SMN1; SMN2
SCHEMBL3430205 0.62 ALDH1A1 (0.45) HSD17B10POLBALDH1A1SMN1; SMN2KDM4E
SCHEMBL25731791 0.61 KDM4E (0.48) HSD17B10CYP3A4ALDH1A1SMN1; SMN2KDM4E
SCHEMBL2674207 0.61 HDAC1 (0.45) HSD17B10POLBCYP3A4ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3053925-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2016-08-10 EP disclosed